Journal of the American Medical Association' raised a red flag, saying the risk of bleeding even from low dose aspirin everyday is greater than they thought."
CardioSource (6/6) reports, "The study, which looked at 186,425 patients being treated with low-dose aspirin and the same number of control patients not using aspirin, is thought to be the first longitudinal study specifically examining the role of diabetes in the incidence of major bleeding in a cohort of individuals, irrespective of the use of aspirin." The study indicates "that aspirin was associated with a 55 percent increase in major bleeding – a finding that suggests the incidence of major bleeding events is much higher than previously shown in other randomized, prospective clinical trials. There also was a higher risk of bleeding among aspirin users younger than 50, in those being treated for hypertension and those using aspirin to relieve pain."
Posted by: Steven Almany MD